Biden Inflation Reduction Act seems to be on its way to passage..With some cuts….

Ok’s have from the Congressional Budget Office and the Senate Parliamentarian….

After getting what they want for their votes?

Democratic Senator’s manchin and Sinema have pledged their votes…

Only 50 Senate votes are needed for this reconciliation bill….

With Vice President Harris set to cast the tie breaker this looks like a win for Biden and the Democrats going into the fall Midterm’s….

Senate Majority Leader Schumer will keep the Senate in session until the Bill is passed …..

The Senate parliamentarian has given the green light to a $740 billion budget reconciliation bill that will reform the tax code, tackle climate change and lower drug prices, putting the Senate on track to begin voting on the bill Saturday afternoon.

Senate Majority Leader Charles Schumer (D-N.Y.) announced Saturday that the bill is on track to pass this weekend now that the parliamentarian, Elizabeth MacDonough, has ruled that its provisions comply with the budgetary rules enabling it to circumvent a GOP filibuster….

…

Schumer said the bill’s major provisions remain “largely intact,” though the parliamentarian did strike a provision that would have limited prescription drug price increases to the rate of inflation. The Senate rules official allowed to the inflation cap to be applied for Medicare beneficiaries but ruled out extending the cap to people with private health insurance.

The Democratic leader said senators should expect to vote sometime Saturday afternoon to begin debate on the legislation.

“In a few hours, we will formally begin the process of passing the Inflation Reduction Act of 2022 by voting on the motion to proceed,” Schumer said.

That will then trigger up to 20 hours of floor debate, followed by votes on an open-ended series of amendments that could last throughout the night and into Sunday morning.

Schumer told colleagues they should expect to keep voting until the bill is finished, likely sometime Sunday….

More… 

Democrats’ plan to control drug prices for 180 million Americans with private health insurance has suffered yet another setback.

The Senate parliamentarian ruled Saturday that a core piece of the party’s plan can’t pass the chamber with fewer than 60 votes, following arguments from both parties last week….

…

The exclusion of the private insurance price limits means there is little left that will reduce costs for the vast majority of Americans who receive health insurance through their private sector employer. Democrats are still waiting on a separate parliamentarian ruling on their policy to cap the cost of insulin both inside and outside of Medicare.

The decision also means tens of billions less in federal savings in the bill overall, a potential threat to Democrats’ hopes of offsetting the cost for shoring up Obamacare’s subsidies.

Still, Democrats argue that the bill will move forward in the coming weeks with its most important provision intact: a repeal of the longstanding ban on the federal government directly negotiating drug prices with pharmaceutical companies….

…

Even if they are able to do so, progressives who originally pushed for much more sweeping drug price controls are disappointed that their already watered-down plan has become even weaker over the past year.

Senate Finance Chair Ron Wyden (D-Ore.), who worked for months on crafting the drug pricing language and wrangling the votes to pass it, blamed the pharmaceutical industry’s influence on Capitol Hill for the inflation cap provision’s demise….

More…